Regional lymph node staging in prostate cancer: prognostic and therapeutic implications

Burkhard, Fiona C; Studer, Urs E (2009). Regional lymph node staging in prostate cancer: prognostic and therapeutic implications. Surgical oncology, 18(3), pp. 213-8. Oxford: Elsevier 10.1016/j.suronc.2009.02.008

Full text not available from this repository. (Request a copy)

The role of pelvic lymph node dissection (PLND) in prostate cancer, in which patients and to what extent it should be performed, remains a controversial topic. Preoperative diagnostic methods are more or less unreliable for lymph node staging and PLND remains the most reliable and accurate method. PLND is indicated in all patients with a PSA value >10 ng/ml and in those with a PSA <10 ng/ml if the Gleason score is > or = 7. If PLND is performed then it should always include the tissue along the external iliac vein, in the obturator fossa and on either side of the internal iliac vessels, up to where the ureter crosses the common iliac vessels. In conjunction with RRP extended PLND may increase staging accuracy, influence decision making with respect to adjuvant therapy and possibly impact outcome.

Item Type:

Journal Article (Further Contribution)


04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology

UniBE Contributor:

Studer, Urs








Factscience Import

Date Deposited:

04 Oct 2013 15:13

Last Modified:

04 May 2014 23:23

Publisher DOI:


PubMed ID:


Web of Science ID:


URI: (FactScience: 197189)

Actions (login required)

Edit item Edit item
Provide Feedback